Melanotan 1
FDA-approved · Grade C
Evidence
5 RCT / 2 animal / 2 in vitro
Half-life
The free-injection form (research chemical, SubQ): plasma half-life approximately 33 minutes from the rapid absorption and distribution phase (Dorr et al., 1996 — the Arizona cl…
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
Melanotan II (MT-II)
Research chemical · Grade C
Goals
beauty, libido, weight-loss
Evidence
2 RCT / 0 animal / 0 in vitro
Routes
injectable-sc, nasal
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
KLOW Stack
Research chemical · Grade C
Goals
gut, immune, healing, beauty
Routes
injectable-sc, topical, oral
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
KPV
Research chemical · Grade C
Goals
healing, beauty, gut, immune
Evidence
0 RCT / 4 animal / 3 in vitro
Routes
oral, injectable-sc, topical
Typical dose
200-500 mcg daily. Oral (capsule or reconstituted oral solution) for gut applications. SubQ injectable for systemic anti-inflammatory effects. Often used in KLOW stack.
Primary mechanism
NF-κB suppression (primary)